ENZENZO BIOCHEM INC

NYSE enzo.com


$ 1.03 $ 0.00 (0 %)    

Friday, 10-May-2024 15:59:17 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 1.04
$ 1.05
$ 0.00 x 0
$ 1.07 x 400
$ 1.03 - $ 1.06
$ 0.99 - $ 2.74
79,316
na
53.27M
$ 0.54
$ 1.64
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-13-2024 01-31-2024 10-Q
2 12-15-2023 10-31-2023 10-Q
3 11-03-2023 07-31-2023 10-K
4 06-14-2023 04-30-2023 10-Q
5 03-20-2023 01-31-2023 10-Q
6 12-12-2022 10-31-2022 10-Q
7 10-14-2022 07-31-2022 10-K
8 06-09-2022 04-30-2022 10-Q
9 03-14-2022 01-31-2022 10-Q
10 12-15-2021 10-31-2021 10-Q
11 10-12-2021 07-31-2021 10-K
12 06-11-2021 04-30-2021 10-Q
13 03-16-2021 01-31-2021 10-Q
14 12-11-2020 10-31-2020 10-Q
15 10-19-2020 07-31-2020 10-K
16 06-09-2020 04-30-2020 10-Q
17 03-06-2020 01-31-2020 10-Q
18 12-10-2019 10-31-2019 10-Q
19 10-15-2019 07-31-2019 10-K
20 06-10-2019 04-30-2019 10-Q
21 03-11-2019 01-31-2019 10-Q
22 12-10-2018 10-31-2018 10-Q
23 10-15-2018 07-31-2018 10-K
24 06-11-2018 04-30-2018 10-Q
25 03-12-2018 01-31-2018 10-Q
26 12-07-2017 10-31-2017 10-Q
27 09-27-2017 07-31-2017 10-K
28 06-08-2017 04-30-2017 10-Q
29 03-13-2017 01-31-2017 10-Q
30 12-08-2016 10-31-2016 10-Q
31 10-13-2016 07-31-2016 10-K
32 06-08-2016 04-30-2016 10-Q
33 03-09-2016 01-31-2016 10-Q
34 12-08-2015 10-31-2015 10-Q
35 10-13-2015 07-31-2015 10-K
36 06-09-2015 04-30-2015 10-Q
37 03-12-2015 01-31-2015 10-Q
38 12-09-2014 10-31-2014 10-Q
39 10-09-2014 07-31-2014 10-K
40 06-09-2014 04-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-pricesmart-shares-are-trading-higher-by-around-5-here-are-20-stocks-moving-premarket

Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expecte...

 heico-emcor-group-and-3-stocks-to-watch-heading-into-monday

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as fol...

 enzo-biochem-q1-eps-013-up-from-022-yoy

Enzo Biochem (NYSE:ENZ) reported quarterly losses of $(0.13) per share. This is a 40.91 percent increase over losses of $(0.22)...

 enzo-biochem-announces-departure-of-hamid-erfanian-and-appointment-of-kara-cannon-as-interim-ceo-effective-september-5-2023

 Enzo Biochem, Inc. (NYSE:ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat o...

 why-alaska-air-group-shares-are-trading-lower-by-9-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.

 why-expion360-holdings-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket

Gainers

 enzo-biochem-q3-eps-031-down-from-010-yoy-sales-1611m-down-from-2622m-yoy

Enzo Biochem (NYSE:ENZ) reported quarterly losses of $(0.31) per share. This is a 210 percent decrease over losses of $(0.10) p...

 enzo-biochem-expects-certain-expenses-related-to-ransomware-attack-including-expenses-to-respond-to-remediate-and-investigate-this-matter

The Company is in the process of evaluating the full scope of the costs and related impacts of this incident.

 enzo-biochem-says-identified-unauthorized-access-to-or-acquisition-of-clinical-test-information-of-approximately-247m-individuals

As previously disclosed, on April 6, 2023, Enzo Biochem experienced a ransomware attack that impacted certain information techn...

 enzo-biochem-reports-significant-progress-towards-completing-the-clinical-lab-asset-sale-special-meeting-of-shareholders-indicate-that-the-asset-sale-proposal-was-approved-by-the-affirmative-vote-of-a-majority-of-enzos-outstanding-common-stock

Enzo Biochem, Inc. (NYSE:ENZ), announced today that  the preliminary voting results from the Inspector of Election at today'...

 enzo-biochem-q2-sales-1630m-down-from-3405m-yoy

Enzo Biochem (NYSE:ENZ) reported $16.30 million in sales this quarter. This is a 52.12 percent decrease over sales of $34.05 mi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION